|

CRD-4730 Clinical Trials

2 actively recruiting trials across 2 locations

▲ +1 trial since August 2026

Pipeline

Phase 2: 2

Top Sponsors

  • Cardurion Pharmaceuticals, Inc.2

Indications

  • Heart Disease2
  • Heart Failure With Reduced Ejection Fraction (HFrEF)1
  • Catecholaminergic Polymorphic Ventricular Tachycardia1

Pasadena, California1 trial

A Trial of CRD-4730 in HFrEF

Cardurion Investigative Site

Phase 2

San Francisco, California1 trial

A Phase 2 Study of CRD-4730 in CPVT

Cardurion Investigative Site

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.